LUPIA, Antonio
LUPIA, Antonio
DIPARTIMENTO DI SCIENZE DELLA VITA E DELL'AMBIENTE
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors
2019-01-01 Costa, G.; Carta, F.; Ambrosio, F. A.; Artese, A.; Ortuso, F.; Moraca, F.; Rocca, R.; Romeo, I.; Lupia, A.; Maruca, A.; Bagetta, D.; Catalano, R.; Vullo, D.; Alcaro, S.; Supuran, C. T.
Computer-based techniques for lead identification and optimization i: Basics
2019-01-01 Maruca, A.; Ambrosio, F. A.; Lupia, A.; Romeo, I.; Rocca, R.; Moraca, F.; Talarico, C.; Bagetta, D.; Catalano, R.; Costa, G.; Artese, A.; Alcaro, S.
Computer-based techniques for lead identification and optimization II: Advanced search methods
2020-01-01 Lupia, A.; Moraca, F.; Bagetta, D.; Maruca, A.; Ambrosio, F. A.; Rocca, R.; Catalano, R.; Romeo, I.; Talarico, C.; Ortuso, F.; Artese, A.; Alcaro, S.
Current updates on naturally occurring compounds recognizing sars-cov-2 druggable targets
2021-01-01 Romeo, I.; Mesiti, F.; Lupia, A.; Alcaro, S.
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype
2023-01-01 Nisticò, Nancy; Aloisio, Annamaria; Lupia, Antonio; Zimbo, Anna Maria; Mimmi, Selena; Maisano, Domenico; Russo, Rossella; Marino, Fabiola; Scalise, Mariangela; Chiarella, Emanuela; Mancuso, Teresa; Fiume, Giuseppe; Omodei, Daniela; Zannetti, Antonella; Salvatore, Giuliana; Quinto, Ileana; Iaccino, Enrico
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
2023-01-01 Di Giorgio, Cristina; Bellini, Rachele; Lupia, Antonio; Massa, Carmen; Bordoni, Martina; Marchianò, Silvia; Rosselli, Rosalinda; Sepe, Valentina; Rapacciuolo, Pasquale; Moraca, Federica; Morretta, Elva; Ricci, Patrizia; Urbani, Ginevra; Monti, Maria Chiara; Biagioli, Michele; Distrutti, Eleonora; Catalanotti, Bruno; Zampella, Angela; Fiorucci, Stefano
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients
2016-01-01 Mimmi, S; Vecchio, E; Iaccino, E; Rossi, M; Lupia, A; Albano, F; Chiurazzi, F; Fiume, G; Pisano, A; Ceglia, S; Pontoriero, M; Golino, G; Tassone, P; Quinto, I; Scala, G; Palmieri, C
Identification of Compounds Targeting HuD. Another Brick in the Wall of Neurodegenerative Disease Treatment
2021-01-01 Ambrosio, F. A.; Coricello, A.; Costa, G.; Lupia, A.; Micaelli, M.; Marchesi, N.; Sala, F.; Pascale, A.; Rossi, D.; Vasile, F.; Alcaro, S.; Collina, S.
In silico food-drug interaction: A case study of eluxadoline and fatty meal
2020-01-01 Maruca, A.; Lupia, A.; Rocca, R.; Keszthelyi, D.; Corsetti, M.; Alcaro, S.
Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators
2018-01-01 Corigliano, D. M.; Syed, R.; Messineo, S.; Lupia, A.; Patel, R.; Reddy, C. V. R.; Dubey, P. K.; Colica, C.; Amato, R.; De Sarro, G.; Alcaro, S.; Indrasena, A.; Brunetti, A.
Inside perspective of the synthetic and computational toolbox of JAK inhibitors: Recent updates
2020-01-01 Coricello, A.; Mesiti, F.; Lupia, A.; Maruca, A.; Alcaro, S.
Is there a role for dual PI3K/mTOR inhibitors for patients affected with lymphoma?
2020-01-01 Tarantelli, C.; Lupia, A.; Stathis, A.; Bertoni, F.
Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders
2022-01-01 Moraca, F.; Marzano, S.; D'Amico, F.; Lupia, A.; Di Fonzo, S.; Vertecchi, E.; Salvati, E.; Di Porzio, A.; Catalanotti, B.; Randazzo, A.; Pagano, B.; Amato, J.
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome
2020-01-01 Bagetta, D.; Maruca, A.; Lupia, A.; Mesiti, F.; Catalano, R.; Romeo, I.; Moraca, F.; Ambrosio, F. A.; Costa, G.; Artese, A.; Ortuso, F.; Alcaro, S.; Rocca, R.
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
2022-01-01 Morgillo, Carmine Marco; Lupia, Antonio; Deplano, Alessandro; Pirone, Luciano; Fiorillo, Bianca; Pedone, Emilia; Luque, F. Javier; Onnis, Valentina; Moraca, Federica; Catalanotti, Bruno
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia
2020-01-01 Lupia, A.; Mimmi, S.; Iaccino, E.; Maisano, D.; Moraca, F.; Talarico, C.; Vecchio, E.; Fiume, G.; Ortuso, F.; Scala, G.; Quinto, I.; Alcaro, S.
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes
2017-01-01 Iaccino, E.; Mimmi, S.; Dattilo, V.; Marino, F.; Candeloro, P.; Di Loria, A.; Marimpietri, D.; Pisano, A.; Albano, F.; Vecchio, E.; Ceglia, S.; Golino, G.; Lupia, A.; Fiume, G.; Quinto, I.; Scala, G.
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors
2020-01-01 Maruca, A.; Lanzillotta, D.; Rocca, R.; Lupia, A.; Costa, G.; Catalano, R.; Moraca, F.; Gaudio, E.; Ortuso, F.; Artese, A.; Trapasso, F.; Alcaro, S.
Peptide platform as a powerful tool in the fight against covid-19
2021-01-01 Murdocca, M.; Citro, G.; Romeo, I.; Lupia, A.; Miersch, S.; Amadio, B.; Bonomo, A.; Rossi, A.; Sidhu, S. S.; Pandolfi, P. P.; Alcaro, S.; Sangiuolo, F. C.; Novelli, G.
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma
2022-01-01 Di Giorgio, C.; Lupia, A.; Marchiano, S.; Bordoni, M.; Bellini, R.; Massa, C.; Urbani, G.; Roselli, R.; Moraca, F.; Sepe, V.; Catalanotti, B.; Morretta, E.; Monti, M. C.; Biagioli, M.; Distrutti, E.; Zampella, A.; Fiorucci, S.
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors | 1-gen-2019 | Costa, G.; Carta, F.; Ambrosio, F. A.; Artese, A.; Ortuso, F.; Moraca, F.; Rocca, R.; Romeo, I.; Lupia, A.; Maruca, A.; Bagetta, D.; Catalano, R.; Vullo, D.; Alcaro, S.; Supuran, C. T. | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
| Computer-based techniques for lead identification and optimization i: Basics | 1-gen-2019 | Maruca, A.; Ambrosio, F. A.; Lupia, A.; Romeo, I.; Rocca, R.; Moraca, F.; Talarico, C.; Bagetta, D.; Catalano, R.; Costa, G.; Artese, A.; Alcaro, S. | PHYSICAL SCIENCES REVIEWS | - |
| Computer-based techniques for lead identification and optimization II: Advanced search methods | 1-gen-2020 | Lupia, A.; Moraca, F.; Bagetta, D.; Maruca, A.; Ambrosio, F. A.; Rocca, R.; Catalano, R.; Romeo, I.; Talarico, C.; Ortuso, F.; Artese, A.; Alcaro, S. | PHYSICAL SCIENCES REVIEWS | - |
| Current updates on naturally occurring compounds recognizing sars-cov-2 druggable targets | 1-gen-2021 | Romeo, I.; Mesiti, F.; Lupia, A.; Alcaro, S. | MOLECULES | - |
| Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype | 1-gen-2023 | Nisticò, Nancy; Aloisio, Annamaria; Lupia, Antonio; Zimbo, Anna Maria; Mimmi, Selena; Maisano, Domenico; Russo, Rossella; Marino, Fabiola; Scalise, Mariangela; Chiarella, Emanuela; Mancuso, Teresa; Fiume, Giuseppe; Omodei, Daniela; Zannetti, Antonella; Salvatore, Giuliana; Quinto, Ileana; Iaccino, Enrico | CELLS | - |
| Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma | 1-gen-2023 | Di Giorgio, Cristina; Bellini, Rachele; Lupia, Antonio; Massa, Carmen; Bordoni, Martina; Marchianò, Silvia; Rosselli, Rosalinda; Sepe, Valentina; Rapacciuolo, Pasquale; Moraca, Federica; Morretta, Elva; Ricci, Patrizia; Urbani, Ginevra; Monti, Maria Chiara; Biagioli, Michele; Distrutti, Eleonora; Catalanotti, Bruno; Zampella, Angela; Fiorucci, Stefano | FRONTIERS IN ONCOLOGY | - |
| Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients | 1-gen-2016 | Mimmi, S; Vecchio, E; Iaccino, E; Rossi, M; Lupia, A; Albano, F; Chiurazzi, F; Fiume, G; Pisano, A; Ceglia, S; Pontoriero, M; Golino, G; Tassone, P; Quinto, I; Scala, G; Palmieri, C | LEUKEMIA | - |
| Identification of Compounds Targeting HuD. Another Brick in the Wall of Neurodegenerative Disease Treatment | 1-gen-2021 | Ambrosio, F. A.; Coricello, A.; Costa, G.; Lupia, A.; Micaelli, M.; Marchesi, N.; Sala, F.; Pascale, A.; Rossi, D.; Vasile, F.; Alcaro, S.; Collina, S. | JOURNAL OF MEDICINAL CHEMISTRY | - |
| In silico food-drug interaction: A case study of eluxadoline and fatty meal | 1-gen-2020 | Maruca, A.; Lupia, A.; Rocca, R.; Keszthelyi, D.; Corsetti, M.; Alcaro, S. | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
| Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators | 1-gen-2018 | Corigliano, D. M.; Syed, R.; Messineo, S.; Lupia, A.; Patel, R.; Reddy, C. V. R.; Dubey, P. K.; Colica, C.; Amato, R.; De Sarro, G.; Alcaro, S.; Indrasena, A.; Brunetti, A. | PEERJ | - |
| Inside perspective of the synthetic and computational toolbox of JAK inhibitors: Recent updates | 1-gen-2020 | Coricello, A.; Mesiti, F.; Lupia, A.; Maruca, A.; Alcaro, S. | MOLECULES | - |
| Is there a role for dual PI3K/mTOR inhibitors for patients affected with lymphoma? | 1-gen-2020 | Tarantelli, C.; Lupia, A.; Stathis, A.; Bertoni, F. | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
| Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders | 1-gen-2022 | Moraca, F.; Marzano, S.; D'Amico, F.; Lupia, A.; Di Fonzo, S.; Vertecchi, E.; Salvati, E.; Di Porzio, A.; Catalanotti, B.; Randazzo, A.; Pagano, B.; Amato, J. | CHEMICAL COMMUNICATIONS | - |
| Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome | 1-gen-2020 | Bagetta, D.; Maruca, A.; Lupia, A.; Mesiti, F.; Catalano, R.; Romeo, I.; Moraca, F.; Ambrosio, F. A.; Costa, G.; Artese, A.; Ortuso, F.; Alcaro, S.; Rocca, R. | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
| Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition | 1-gen-2022 | Morgillo, Carmine Marco; Lupia, Antonio; Deplano, Alessandro; Pirone, Luciano; Fiorillo, Bianca; Pedone, Emilia; Luque, F. Javier; Onnis, Valentina; Moraca, Federica; Catalanotti, Bruno | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
| Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia | 1-gen-2020 | Lupia, A.; Mimmi, S.; Iaccino, E.; Maisano, D.; Moraca, F.; Talarico, C.; Vecchio, E.; Fiume, G.; Ortuso, F.; Scala, G.; Quinto, I.; Alcaro, S. | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
| Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes | 1-gen-2017 | Iaccino, E.; Mimmi, S.; Dattilo, V.; Marino, F.; Candeloro, P.; Di Loria, A.; Marimpietri, D.; Pisano, A.; Albano, F.; Vecchio, E.; Ceglia, S.; Golino, G.; Lupia, A.; Fiume, G.; Quinto, I.; Scala, G. | MOLECULAR CANCER | - |
| Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors | 1-gen-2020 | Maruca, A.; Lanzillotta, D.; Rocca, R.; Lupia, A.; Costa, G.; Catalano, R.; Moraca, F.; Gaudio, E.; Ortuso, F.; Artese, A.; Trapasso, F.; Alcaro, S. | MOLECULES | - |
| Peptide platform as a powerful tool in the fight against covid-19 | 1-gen-2021 | Murdocca, M.; Citro, G.; Romeo, I.; Lupia, A.; Miersch, S.; Amadio, B.; Bonomo, A.; Rossi, A.; Sidhu, S. S.; Pandolfi, P. P.; Alcaro, S.; Sangiuolo, F. C.; Novelli, G. | VIRUSES | - |
| Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma | 1-gen-2022 | Di Giorgio, C.; Lupia, A.; Marchiano, S.; Bordoni, M.; Bellini, R.; Massa, C.; Urbani, G.; Roselli, R.; Moraca, F.; Sepe, V.; Catalanotti, B.; Morretta, E.; Monti, M. C.; Biagioli, M.; Distrutti, E.; Zampella, A.; Fiorucci, S. | CELLS | - |